Report Detail

Request for Sample of this report

Other Global (United States, European Union and China) Radiopharmaceuticals in Nuclear Medicine Market Research Report 2019-2025

  • RnM3471180
    • |
  • 16 April, 2020
    • |
  • Global
    • |
  • 138 Pages
    • |
  • QYResearch
    • |
  • Other

The global Radiopharmaceuticals in Nuclear Medicine market is valued at US$ 4697 million in 2020 is expected to reach US$ 6655.4 million by the end of 2026, growing at a CAGR of 5.0% during 2021-2026.
This report focuses on Radiopharmaceuticals in Nuclear Medicine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Radiopharmaceuticals in Nuclear Medicine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Radiopharmaceuticals in Nuclear Medicine market is segmented into
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes

Segment by Application
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other

Global Radiopharmaceuticals in Nuclear Medicine Market: Regional Analysis
The Radiopharmaceuticals in Nuclear Medicine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Radiopharmaceuticals in Nuclear Medicine market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Radiopharmaceuticals in Nuclear Medicine Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Radiopharmaceuticals in Nuclear Medicine market include:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)


Table of Contents

    1 Radiopharmaceuticals in Nuclear Medicine Market Overview

    • 1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine
    • 1.2 Radiopharmaceuticals in Nuclear Medicine Segment by Type
      • 1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Diagnostic Radiopharmaceuticals
      • 1.2.3 Therapy Radiopharmaceuticals
      • 1.2.4 Enriched Stable Isotopes
    • 1.3 Radiopharmaceuticals in Nuclear Medicine Segment by Application
      • 1.3.1 Radiopharmaceuticals in Nuclear Medicine Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Diagnostic Application
      • 1.3.3 Therapeutic Application
      • 1.3.4 Research
      • 1.3.5 Pharmaceutical
      • 1.3.6 Other
    • 1.4 Global Radiopharmaceuticals in Nuclear Medicine Market Size Estimates and Forecasts
      • 1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue 2015-2026
      • 1.4.2 Global Radiopharmaceuticals in Nuclear Medicine Sales 2015-2026
      • 1.4.3 Radiopharmaceuticals in Nuclear Medicine Market Size by Region: 2020 Versus 2026

    2 Global Radiopharmaceuticals in Nuclear Medicine Market Competition by Manufacturers

    • 2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Radiopharmaceuticals in Nuclear Medicine Manufacturing Sites, Area Served, Product Type
    • 2.5 Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation and Trends
      • 2.5.1 Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Radiopharmaceuticals in Nuclear Medicine Players (Opinion Leaders)

    3 Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario by Region

    • 3.1 Global Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Country
      • 3.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country
      • 3.3.2 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Country
      • 3.4.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country
      • 3.4.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region
      • 3.5.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Country
      • 3.6.1 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country
      • 3.6.2 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country
      • 3.7.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Radiopharmaceuticals in Nuclear Medicine Historic Market Analysis by Type

    • 4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
    • 4.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2015-2020)
    • 4.3 Global Radiopharmaceuticals in Nuclear Medicine Price Market Share by Type (2015-2020)
    • 4.4 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Radiopharmaceuticals in Nuclear Medicine Historic Market Analysis by Application

    • 5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
    • 5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2015-2020)
    • 5.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Radiopharmaceuticals in Nuclear Medicine Business

    • 6.1 Bracco Imaging S.P.A.
      • 6.1.1 Corporation Information
      • 6.1.2 Bracco Imaging S.P.A. Description, Business Overview and Total Revenue
      • 6.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Bracco Imaging S.P.A. Products Offered
      • 6.1.5 Bracco Imaging S.P.A. Recent Development
    • 6.2 Cambridge Isotope Laboratories, Inc.
      • 6.2.1 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.2.2 Cambridge Isotope Laboratories, Inc. Description, Business Overview and Total Revenue
      • 6.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Cambridge Isotope Laboratories, Inc. Products Offered
      • 6.2.5 Cambridge Isotope Laboratories, Inc. Recent Development
    • 6.3 Cardinal Health, Inc.
      • 6.3.1 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.3.2 Cardinal Health, Inc. Description, Business Overview and Total Revenue
      • 6.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Cardinal Health, Inc. Products Offered
      • 6.3.5 Cardinal Health, Inc. Recent Development
    • 6.4 Covidien, Plc
      • 6.4.1 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.4.2 Covidien, Plc Description, Business Overview and Total Revenue
      • 6.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Covidien, Plc Products Offered
      • 6.4.5 Covidien, Plc Recent Development
    • 6.5 Eczacibasi-Monrol
      • 6.5.1 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.5.2 Eczacibasi-Monrol Description, Business Overview and Total Revenue
      • 6.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Eczacibasi-Monrol Products Offered
      • 6.5.5 Eczacibasi-Monrol Recent Development
    • 6.6 Fujifilm Holdings Corporation
      • 6.6.1 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.6.2 Fujifilm Holdings Corporation Description, Business Overview and Total Revenue
      • 6.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Fujifilm Holdings Corporation Products Offered
      • 6.6.5 Fujifilm Holdings Corporation Recent Development
    • 6.7 GE Healthcare (Subsidiary Of General Electric Company)
      • 6.6.1 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.6.2 GE Healthcare (Subsidiary Of General Electric Company) Description, Business Overview and Total Revenue
      • 6.6.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 GE Healthcare (Subsidiary Of General Electric Company) Products Offered
      • 6.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
    • 6.8 IBA Group
      • 6.8.1 IBA Group Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.8.2 IBA Group Description, Business Overview and Total Revenue
      • 6.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 IBA Group Products Offered
      • 6.8.5 IBA Group Recent Development
    • 6.9 Isotec, Inc. (Sigma-Aldrich)
      • 6.9.1 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.9.2 Isotec, Inc. (Sigma-Aldrich) Description, Business Overview and Total Revenue
      • 6.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 Isotec, Inc. (Sigma-Aldrich) Products Offered
      • 6.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Development
    • 6.10 Lantheus Medical Imaging, Inc.
      • 6.10.1 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.10.2 Lantheus Medical Imaging, Inc. Description, Business Overview and Total Revenue
      • 6.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Lantheus Medical Imaging, Inc. Products Offered
      • 6.10.5 Lantheus Medical Imaging, Inc. Recent Development
    • 6.11 Nordion, Inc.
      • 6.11.1 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.11.2 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Nordion, Inc. Products Offered
      • 6.11.5 Nordion, Inc. Recent Development
    • 6.12 Ntp Radioisotopes (Pty), Ltd.
      • 6.12.1 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.12.2 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 Ntp Radioisotopes (Pty), Ltd. Products Offered
      • 6.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Development
    • 6.13 Siemens Healthcare (Subsidiary Of Siemens AG)
      • 6.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Products Offered
      • 6.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Development
    • 6.14 Taiyo Nippon Sanso Corporation
      • 6.14.1 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.14.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.14.4 Taiyo Nippon Sanso Corporation Products Offered
      • 6.14.5 Taiyo Nippon Sanso Corporation Recent Development
    • 6.15 Urenco Limited
      • 6.15.1 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.15.2 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.15.4 Urenco Limited Products Offered
      • 6.15.5 Urenco Limited Recent Development
    • 6.16 Rotem Industries, Ltd., Inc.
      • 6.16.1 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.16.2 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.16.4 Rotem Industries, Ltd., Inc. Products Offered
      • 6.16.5 Rotem Industries, Ltd., Inc. Recent Development
    • 6.17 Australian Nuclear Association And Technology Organization (ANSTO)
      • 6.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Products Offered
      • 6.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Development
    • 6.18 Board of Radiation And Isotope Technology (BRIT)
      • 6.18.1 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.18.2 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.18.4 Board of Radiation And Isotope Technology (BRIT) Products Offered
      • 6.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Development
    • 6.19 Institute of Atomic Energy Polatom Radioisotope Centre
      • 6.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Products Offered
      • 6.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Development
    • 6.20 Institute of Isotopes Co., Ltd.
      • 6.20.1 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.20.2 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.20.4 Institute of Isotopes Co., Ltd. Products Offered
      • 6.20.5 Institute of Isotopes Co., Ltd. Recent Development
    • 6.21 Institute Of Radioelement (IRE)
      • 6.21.1 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
      • 6.21.2 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Description, Business Overview and Total Revenue
      • 6.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2015-2020)
      • 6.21.4 Institute Of Radioelement (IRE) Products Offered
      • 6.21.5 Institute Of Radioelement (IRE) Recent Development

    7 Radiopharmaceuticals in Nuclear Medicine Manufacturing Cost Analysis

    • 7.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
    • 7.4 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Radiopharmaceuticals in Nuclear Medicine Distributors List
    • 8.3 Radiopharmaceuticals in Nuclear Medicine Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Radiopharmaceuticals in Nuclear Medicine Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Radiopharmaceuticals in Nuclear Medicine by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Radiopharmaceuticals in Nuclear Medicine by Type (2021-2026)
    • 10.2 Radiopharmaceuticals in Nuclear Medicine Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Radiopharmaceuticals in Nuclear Medicine by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Radiopharmaceuticals in Nuclear Medicine by Application (2021-2026)
    • 10.3 Radiopharmaceuticals in Nuclear Medicine Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Radiopharmaceuticals in Nuclear Medicine by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Radiopharmaceuticals in Nuclear Medicine by Region (2021-2026)
    • 10.4 North America Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2021-2026)
    • 10.5 Europe Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2021-2026)
    • 10.7 Latin America Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:
      Get latest Market Research Reports on Radiopharmaceuticals in Nuclear Medicine . Industry analysis & Market Report on Radiopharmaceuticals in Nuclear Medicine is a syndicated market report, published as Global (United States, European Union and China) Radiopharmaceuticals in Nuclear Medicine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Radiopharmaceuticals in Nuclear Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$2,900.00
      		$4,350.00
      		$5,800.00
      		2,241.70
      		3,362.55
      		4,483.40
      		2,699.90
      		4,049.85
      		5,399.80
      		442,801.00
      		664,201.50
      		885,602.00
      		244,760.00
      		367,140.00
      		489,520.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo